Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruyuki Ariga

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Kekkaku : [Tuberculosis]|November 5, 2008
[Evolution of IGRA researches]Haruyuki Ariga, Nobuyuki Harada
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|May 13, 2011
[Six adult cases of respiratory complications caused by pandemic 2009 influenza A (H1N1) compared to seasonal influenza]Yu Mikami, Haruyuki Ariga, Nobuharu Ohshima, et al.
Rinsho Shinkeigaku = Clinical Neurology|September 1, 2009
[Interferon-gamma release assay in cerebrospinal fluid of a patient with tuberculous meningitis: a case report]Ayumi Uchibori, Tai Miyazaki, Haruyuki Ariga, et al.
Tuberculosis Research and Treatment|May 9, 2012
Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised PopulationsHaruyuki Ariga, Hideaki Nagai, Atsuyuki Kurashima, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 19, 2010
[Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab]Naoki Takasaka, Emiko Toyota, Masahiro Shimada, et al.
The Journal of Infection|June 1, 2011
Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levelsKosaku Komiya, Haruyuki Ariga, Hideaki Nagai, et al.
Immunology|January 21, 2006
Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptideTakeshi Kikuchi, Shuichiro Uehara, Haruyuki Ariga, et al.
Internal Medicine (Tokyo, Japan)|September 9, 2010
Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosisKosaku Komiya, Haruyuki Ariga, Hideaki Nagai, et al.
Immunology|May 11, 2007
Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signalsHaruyuki Ariga, Yoko Shimohakamada, Makiyo Nakada, et al.
Japanese Journal of Infectious Diseases|May 24, 2013
Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigensYoshiro Yamashita, Yoshihiko Hoshino, Mayuko Oka, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Kekkaku : [Tuberculosis]|November 5, 2008
[Evolution of IGRA researches]Haruyuki Ariga, Nobuyuki Harada
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|May 13, 2011
[Six adult cases of respiratory complications caused by pandemic 2009 influenza A (H1N1) compared to seasonal influenza]Yu Mikami, Haruyuki Ariga, Nobuharu Ohshima, et al.
Rinsho Shinkeigaku = Clinical Neurology|September 1, 2009
[Interferon-gamma release assay in cerebrospinal fluid of a patient with tuberculous meningitis: a case report]Ayumi Uchibori, Tai Miyazaki, Haruyuki Ariga, et al.
Tuberculosis Research and Treatment|May 9, 2012
Stratified Threshold Values of QuantiFERON Assay for Diagnosing Tuberculosis Infection in Immunocompromised PopulationsHaruyuki Ariga, Hideaki Nagai, Atsuyuki Kurashima, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|February 19, 2010
[Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab]Naoki Takasaka, Emiko Toyota, Masahiro Shimada, et al.
The Journal of Infection|June 1, 2011
Reversion rates of QuantiFERON-TB Gold are related to pre-treatment IFN-gamma levelsKosaku Komiya, Haruyuki Ariga, Hideaki Nagai, et al.
Immunology|January 21, 2006
Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptideTakeshi Kikuchi, Shuichiro Uehara, Haruyuki Ariga, et al.
Internal Medicine (Tokyo, Japan)|September 9, 2010
Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosisKosaku Komiya, Haruyuki Ariga, Hideaki Nagai, et al.
Immunology|May 11, 2007
Instruction of naive CD4+ T-cell fate to T-bet expression and T helper 1 development: roles of T-cell receptor-mediated signalsHaruyuki Ariga, Yoko Shimohakamada, Makiyo Nakada, et al.
Japanese Journal of Infectious Diseases|May 24, 2013
Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigensYoshiro Yamashita, Yoshihiko Hoshino, Mayuko Oka, et al.
Pageof 3